Other Names for This Medicine Generic Name Brand Name acetohexamide Dymelor chlorpropamide Diabinese glimepiride Amaryl glipizide Glucotrol, Glucotrol XL
glyburide DiaBeta, Glynase PresTab, Micronase tolazamide Tolinase tolbutamide Orinase
(glipizide extended release tablets) is indicated as an adjunct to diet for the control of hyperglycemia in patients with type-2 diabetes.
These results include the November 20, 2003, launch of generic Glucotrol XL
, licensed from Pfizer, Inc.
5 mg strength of generic Glucotrol XL
during the week of November 24, 2003.
The Company will be able to launch bioequivalent versions of Glucotrol XL
(as further discussed below) in the fourth quarter of 2003.
As recently announced, the Andrx ANDA for the 10 mg strength of Glucotrol XL
has received tentative FDA approval.
Indicated for the treatment of Type II diabetes, the 10mg strength of Glucotrol XL
had $217 million of brand sales in 2002, according to IMS data.
The leading five oral antidiabetic products sold through pharmacies for the 12 months through September 2000 are Bristol-Myers Squibb's Glucophage, GlaxoSmithKline's Avandia, Takeda's Actos, Aventis's Amaryl and Pfizer's Glucotrol XL